Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human monkeypox Italian locoregional small cluster.
Bassi A, Piccolo V, de Gennaro M, Simoni B, Mazzatenta C. Bassi A, et al. Among authors: simoni b. Travel Med Infect Dis. 2022 Nov-Dec;50:102471. doi: 10.1016/j.tmaid.2022.102471. Epub 2022 Oct 8. Travel Med Infect Dis. 2022. PMID: 36216231 Free PMC article. No abstract available.
Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study.
Dragotto M, Capalbo E, Cartocci A, Manzo Margiotta F, Michelucci A, Rosi E, Ricceri F, Simoni B, Savarese I, Milanesi N, Rossari S, Magnano M, Romanelli M, Rubegni P, Prignano F, Di Cesare A, Panduri S, Pescitelli L, Trovato E. Dragotto M, et al. Among authors: simoni b. J Eur Acad Dermatol Venereol. 2023 Apr 16. doi: 10.1111/jdv.19117. Online ahead of print. J Eur Acad Dermatol Venereol. 2023. PMID: 37062048 No abstract available.
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas.
Michelucci A, Margiotta FM, Cartocci A, Panduri S, Trovato E, Calpalbo E, Dragotto M, Di Cesare A, Rosi E, Rossari S, Magnano M, Pescitelli L, Buggiani G, Simoni B, Lorenzoni E, Ricceri F, Savarese I, Milanesi N, Rubegni P, Prignano F, Romanelli M. Michelucci A, et al. Among authors: simoni b. Arch Dermatol Res. 2024 May 25;316(6):272. doi: 10.1007/s00403-024-03146-2. Arch Dermatol Res. 2024. PMID: 38796581
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation.
Manzo Margiotta F, Michelucci A, Capalbo E, Ricceri F, Rosi E, Rossari S, Magnano M, Savarese I, Milanesi N, Simoni B, Romanelli M, Rubegni P, DI Cesare A, Panduri S, Pescitelli L, Trovato E, Prignano F. Manzo Margiotta F, et al. Among authors: simoni b. Ital J Dermatol Venerol. 2024 Feb;159(1):64-65. doi: 10.23736/S2784-8671.23.07648-X. Epub 2023 Nov 23. Ital J Dermatol Venerol. 2024. PMID: 37997317 No abstract available.